中国药事
中國藥事
중국약사
CHINESE PHARMACEUTICAL AFFAIRS
2015年
1期
79-82
,共4页
药品不良反应%合理用药%静脉用药%抗感染药物%监测报告分析
藥品不良反應%閤理用藥%靜脈用藥%抗感染藥物%鑑測報告分析
약품불량반응%합리용약%정맥용약%항감염약물%감측보고분석
adverse drug reactions%rational drug use%intravenous drug use%anti-infective drugs%monitoring report analysis
目的：了解我院药品不良反应(ADR)发生情况及特点，为临床合理用药提供依据。方法：对2013年收集并上报的176例药品不良反应报告进行回顾性分析。结果：176例ADR中，40～60岁患者较多，占总例数的41.48%(73例)；给药方式以静脉给药引发的ADR最多，占总例数的82.25%(143例)；药物类别以抗感染药物引起的ADR最多，占总例数的37.50%(66例)；临床表现以皮肤及附件损伤最常见，占总例数的28.98%(51例)。结论：应进一步重视和加强ADR监测工作，减少静脉用药，避免或减少ADR重复发生，促进临床合理用药。
目的：瞭解我院藥品不良反應(ADR)髮生情況及特點，為臨床閤理用藥提供依據。方法：對2013年收集併上報的176例藥品不良反應報告進行迴顧性分析。結果：176例ADR中，40～60歲患者較多，佔總例數的41.48%(73例)；給藥方式以靜脈給藥引髮的ADR最多，佔總例數的82.25%(143例)；藥物類彆以抗感染藥物引起的ADR最多，佔總例數的37.50%(66例)；臨床錶現以皮膚及附件損傷最常見，佔總例數的28.98%(51例)。結論：應進一步重視和加彊ADR鑑測工作，減少靜脈用藥，避免或減少ADR重複髮生，促進臨床閤理用藥。
목적：료해아원약품불량반응(ADR)발생정황급특점，위림상합리용약제공의거。방법：대2013년수집병상보적176례약품불량반응보고진행회고성분석。결과：176례ADR중，40～60세환자교다，점총례수적41.48%(73례)；급약방식이정맥급약인발적ADR최다，점총례수적82.25%(143례)；약물유별이항감염약물인기적ADR최다，점총례수적37.50%(66례)；림상표현이피부급부건손상최상견，점총례수적28.98%(51례)。결론：응진일보중시화가강ADR감측공작，감소정맥용약，피면혹감소ADR중복발생，촉진림상합리용약。
Objective:To study the occurrence and features of adverse drug reactions (ADRs) in The People's Hospital of Wuzhou, China hospital so as to provide reference for clinical rational drug use. Methods:Totally 176 ADR cases collected in the year 2013 were analyzed retrospectively. Results:In the total 176 ADR cases, the ADRs mostly occurred in patients aged 40 to 60 years, accounting for 41.48% (73 cases). According to administration route, the ADRs caused by intravenous administration were most common, accounting for 82.25%(143 cases). According to drug type, the ADRs caused by anti-infective drugs mostly occurred, accounting for 37.50%(66 cases). Skin and appendage damage were the most common clinical manifestations, accounting for 28.98%(51 cases). Conclusion:More attention should be paid to monitoring the incidence of ADRs. Clinicians should reduce the intravenous drug use, avoid or reduce the repeated occurrences of ADRs, and promote reasonable use of drugs.
